Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Henry Seth Friedman

1-50 of 511 results

IDH1 and IDH2 mutations in gliomas

scientific article

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

scientific article (publication date: October 2009)

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

scientific article published in October 2007

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

scientific article published on 25 March 2013

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

scientific article published in February 2007

Identification of p53 as a sequence-specific DNA-binding protein

scientific article

The genetic landscape of the childhood cancer medulloblastoma

scientific article

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

scientific article published on October 4, 2010

Phase II trial of gefitinib in recurrent glioblastoma

scientific article published on 24 November 2003

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

scientific article

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

scientific article published in June 1993

The pediatric preclinical testing program: description of models and early testing results.

scientific article published in December 2007

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

scientific article

Temozolomide and treatment of malignant glioma.

scientific article

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

scientific article published on June 1, 1990

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

scientific article published on December 10, 2010

Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study

scientific article (publication date: September 1998)

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

scientific article published on March 11, 2015

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

scientific article published in December 1998

Irinotecan therapy in adults with recurrent or progressive malignant glioma

scientific article

Recent advances in the treatment of malignant astrocytoma

scientific article

Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan

scientific article published on January 2008

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

scientific article

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

scientific article

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

scientific article published on August 1999

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study

scientific article published on May 1, 1998

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

scientific article

Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6

scientific article

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

scientific article

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

scientific article published in October 2003

Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.

scientific article published on December 1990

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

scientific article

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

scientific article published on 10 April 2008

Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.

scientific article published on October 1995

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

scientific article

Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma

scientific article

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

scientific article

PTEN gene mutations are seen in high-grade but not in low-grade gliomas

scientific article published on October 1, 1997

Poor drug distribution as a possible explanation for the results of the PRECISE trial

scientific article published in August 2010

Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion

scientific article

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

scientific article

Phase II trial of temozolomide in patients with progressive low-grade glioma

scientific article

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

scientific article published on June 2007

Structural chromosomal abnormalities in human medulloblastoma

scientific article published in January 1988

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

scientific article

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

scientific article

Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors

scientific article published on September 15, 2003

Recurrent Glioblastoma Treated with Recombinant Poliovirus

scientific article

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

scientific article published on November 2008

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

scientific article